Is Chemotherapy Implicated in the Development of Hypopituitarism in Childhood Cancer Survivors?

J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgz132. doi: 10.1210/clinem/dgz132.

Authors

Khyatisha Seejore^{1

2}, Nikolaos Kyriakakis^{1

2}, Robert D Murray^{1

2}

Affiliations

¹ Leeds Centre for Diabetes and Endocrinology, Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
² Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK.

PMID: 31665329
DOI: 10.1210/clinem/dgz132

No abstract available

Keywords: chemotherapy; childhood cancer survivors; growth hormone deficiency; hypopituitarism.

Publication types

Comment

MeSH terms

Cancer Survivors*
Child
Humans
Hypopituitarism* / chemically induced
Hypopituitarism* / epidemiology
Neoplasms* / drug therapy
Outcome Assessment, Health Care
Prevalence
Risk Factors